Clinical Trial

Cerebral Physiology of NOWS

Study acronym: NIRS for NOWS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.
Protocol Amendment History 1 change
notable Primary completion pushed: 2027-04 -> 2027-06 2026-06-06
Trial Details
NCT Number NCT07610746
Lead Sponsor Indiana University
Collaborators: Indiana Clinical and Translational Sciences Institute, National Institute on Drug Abuse (NIDA)
Conditions Neonatal Opioid Withdrawal, Neonatal Opioid Withdrawal Syndrome, Opioid Use Disorder, Intrauterine Exposure
Enrollment 46 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-05